Watch Demo

Belgium Anti Rheumatic Industry Outlook 2022 - 2026

See how Belgium Anti Rheumatic performed compared to key markets such as South Korea, Germany and Spain.

Key Market Indicators

Belgian antirheumatic medicine sales are expected to reach $90 million by 2026. In 2021, the market was valued at $102 million. This represents a projected decrease of 2.3% each year since 2007. Belgium was the 6th largest market in 2021. Italy overtook the country with sales of $103 million. Germany, Spain, and Canada were the next three biggest markets, in that order.

Marketing Banner

Belgium Anti Rheumatic Market Data and Forecasts

How much will Belgium Anti Rheumatic Market grow to 2026?

Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Use in Belgium
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Belgium
Forecast: Non-Steroids Antiinflammatory and Antirheumatic Medicine Sales in Belgium
More in Anti Rheumatic Industry for 2028

Improve your Knowledge with the latest Indicators and Trends